Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01968824 · ClinicalTrials.gov registry record · NA

Brachial Plexus Block in Post-Op Pain Control After Distal Upper Extremity Fracture: A Prospective Randomized Study

A NA study of Pain, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
99
Enrollment target
1
Study location

NCT01968824: Completed NA study of Pain, sponsored by NYU Langone Health.

NCT01968824 is a NA study of Pain that has completed, run by NYU Langone Health. The registered enrollment target is 99 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01968824, a NA study of Pain, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
99 participants
Enrollment target
1
Study location

Study Summary

Despite the plethora of literature suggesting that regional blockade provides adequate andimproved postoperative pain control, function and improved intraoperative and postoperative safety in proximal upper extremity surgery, little is known of its benefits for the treatment of forearm and distal radius fractures . The purpose of this randomized, prospective, study is to determine if brachial plexus blockade with general anesthesia is superior to general anesthesia alone in immediate and long-term pain control in patients undergoing operative fixation of distal upper extremity fractures.

Primary Outcome

post-operative pain will be measured at various time points

Conditions Studied

Interventions

  • PROCEDURE Brachial Plexus Nerve Block

Study Locations (1)

New York

  • New York University Langone Medical Center - New York

Trial Details

FieldValue
Enrollment Target 99 participants
Start Date 2013-01
Est. Completion 2016-07
Phase NA
NYU Langone Health

1,164 total trials

What the finished NCT01968824 record still lists

NCT01968824 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (67% lower).

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Brachial Plexus Nerve Block is the first listed.

NCT01968824 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT01968824 about?

NCT01968824 is a clinical study titled "Brachial Plexus Block in Post-Op Pain Control After Distal Upper Extremity Fracture: A Prospective Randomized Study". Despite the plethora of literature suggesting that regional blockade provides adequate andimproved postoperative pain control, function and improved intraoperative and postoperative safety in proximal upper extremity surgery, little is known of its benefits for the treatment of forearm and distal ra...

What is the current status of trial NCT01968824?

This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2013-01. Estimated completion is 2016-07.

What conditions does trial NCT01968824 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT01968824?

The interventions under investigation include: Brachial Plexus Nerve Block (PROCEDURE).

Who is sponsoring clinical trial NCT01968824?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01968824 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01968824's enrollment target sits among peer trials

99 175th of 374 higher than 200 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03965234 · 99 participants · Phase 1

    Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

  • NCT04022616 · 99 participants

    Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

  • NCT04042844 · 99 participants · Phase 2

    A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)

  • NCT04143724 · 99 participants · Phase 2

    Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01968824, the US trial registry maintained by the National Library of Medicine. NCT01968824 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.